Search

Puede ser difícil comprender las diversas opciones de radioterapia utilizadas para tratar el cáncer de próstata. Aquí las explicamos.

… Wednesday, July 2, 2025 Cuando se trata de tratamiento para el cáncer de próstata , actualmente los hombres cuentan con muchas opciones que han mejorado la prevención de la enfermedad. Un tratamiento eficaz es la radioterapia, sola o combinada con otros tratamientos como la terapia hormonal o la cirugía

Scientists at Memorial Sloan Kettering have pieced together the biochemical mechanism by which the tuberculosis bacterium sneaks past our immune defenses.

… Tuesday, June 15, 2021 Tuberculosis (TB) isn’t very common in the US, but worldwide it causes an immense amount of suffering. “It’s a persistent, decades-long pandemic,” says Michael Glickman , an infectious disease specialist at Memorial Sloan Kettering and member of the Immunology Program in the Sloan

Read about a powerful research model developed by MSK researchers to learn how the most common type of prostate cancer changes into a deadly form.

… Wednesday, October 16, 2024 A leading scientist whose discoveries about prostate cancer led to lifesaving treatments is now shedding light on an emerging and deadlier form of the disease: neuroendocrine prostate cancer (NEPC). Most prostate cancers are classified as adenocarcinomas, which rely on a protein

MSK physician-scientist Prasad Adusumilli is focused on developing more-effective immunotherapy approaches for treating tumors in the chest.

… Tuesday, October 11, 2016 Summary MSK physician-scientist Prasad Adusumilli is focused on developing more-effective immunotherapy approaches for treating tumors in the chest. This magnified image shows immune cells, in blue, attacking and killing mesothelioma cells, in magenta. (Cells have been artificially

During the June 8 edition of “MSK Science Spotlight,” radiochemist Jason Lewis, PhD, will share his perspectives on “Defying the Limitations of Antibodies for Imaging and Endoradiotherapy.”

… Monday, June 8, 2020 During the June 8 edition of “ MSK Science Spotlight ,” radiochemist Jason Lewis , PhD, will share his perspectives on “Defying the Limitations of Antibodies for Imaging and Endoradiotherapy.” Dr. Lewis is Vice Chair for Research, Department of Radiology and Chief, Radiochemistry

Genetic analysis reveals biomarkers and possible drug targets for malignant peripheral nerve sheath tumors.

… Thursday, October 9, 2014 Summary Genetic analysis reveals biomarkers and possible drug targets for malignant peripheral nerve sheath tumors. A recent Memorial Sloan Kettering study suggests new ways to control malignant peripheral nerve sheath tumors (MPNSTs), a rare, aggressive type of soft tissue

Learn more about Memorial Sloan Kettering’s newsletter for cancer survivors, which is celebrating its tenth year of publication.

… Thursday, June 21, 2018 Summary Bridges , Memorial Sloan Kettering’s newsletter for cancer survivors, is celebrating its tenth year of publication. Since its inception, Bridges has connected and inspired people who have faced cancer and the challenges that come with it. The quarterly publication is written

Learn about the role of radiation therapy in protecting women from breast cancer recurrence after breast-conserving surgery.

… Wednesday, June 3, 2020 Summary Radiation therapy given after breast-conserving surgery ( lumpectomy ) has proven effective at preventing the cancer from coming back. Learn more about different radiation therapy approaches for women with breast cancer and how to decide what is best for you. Women with

In a large-scale genomic analysis of the most common and aggressive type of ovarian cancer, researchers from Memorial Sloan Kettering and other centers identified genetic mutations and pathways that set the disease apart from other types of ovarian cancer and other solid tumors.

… Saturday, October 1, 2011 Summary In a large-scale genomic analysis of the most common and aggressive type of ovarian cancer, researchers from Memorial Sloan Kettering and other centers identified genetic mutations and pathways that set the disease apart from other types of ovarian cancer and other solid

While BRCA genes garner most of the public's attention, they're not the only cancer-predisposition genes doctors test for.

… Friday, October 18, 2019 Summary The science of clinical genetics is helping doctors understand more about the genes that increase a person’s risk of cancer, and which ones warrant genetic testing. When it comes to genes that predispose to cancer, most people have heard of BRCA1 and BRCA2 . Inherited